Riskpilot← Back to searchSign inGet full accessEMV Pharma AB
ABActiveOrg 5592728538Skördevägen 8Other non-specialised retail sale · NACE 4712Est. 20200 employees
Revenue 2025
SEK 0
EBITDA margin
—
+50% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -952
+58% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +50% |
| Net profit | SEK -952 | +58% |
| Total assets | SEK 20K | -5% |
| Equity | SEK 20K | -5% |
| Employees | 0 | — |
Legal name
EMV Pharma AB
Org number
5592728538
Legal form
Aktiebolag
NACE code
4712 · Other non-specialised retail sale
Founded
23 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva internet- och butiksförsäljning av hälsokost av medical purpose och därmed förenlig verksamhet.
Address
Skördevägen 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — |
| EBITDA | −11 | 9 | −3 | −1 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | −11 | 9 | −3 | −1 |
| Net financials | — | 0 | 0 | 0 |
| Profit before tax | −11 | 9 | −2 | −1 |
| Tax | −0 | — | — | — |
| Net profit | −11 | 9 | −2 | −1 |
| Item | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 24 | 23 | 21 | 20 |
| Equity | 14 | 23 | 21 | 20 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 10 | 0 | — | — |
| Total debt | 10 | — | — | — |
EBITDA margin
-130000.0%
This company
15.8%
Market median
-822885% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
-4.8%
This company
18.4%
Market median
-126% vs market
20212025
Net profit margin
-95200.0%
This company
8.1%
Market median
-1175409% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-01-01 – 2024-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EMV Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Linda Marie Borg | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Nera Marie Voglis Borg | Board of Directors | 0 companies |
| Evaggelos Georgios Voglis | Board of Directors | 0 companies |